hypertension - Nursing Case Study
Pathophysiology
• Primary mechanism: Increased peripheral resistance - Hypertension often begins with elevated peripheral vascular resistance due to narrowed and stiffened arteries, largely from atherosclerosis or chronic stress, causing the heart to work harder to pump blood through these constricted vessels.
• Secondary mechanism: Overactivity of the Renin-Angiotensin-Aldosterone System (RAAS) - This hormonal system, when overactive, leads to vasoconstriction and increased blood volume by promoting sodium and water retention, further elevating blood pressure.
• Key complication: End-organ damage - Persistent high blood pressure can lead to critical complications such as left ventricular hypertrophy, renal impairment, and increased risk of stroke due to the constant strain on the cardiovascular system.
Patient Profile
Demographics:
56-year-old female, office manager
History:
• Key past medical history: Hypertension diagnosed 5 years ago, borderline type 2 diabetes, family history of cardiovascular disease
• Current medications: Lisinopril 20 mg daily, Metformin 500 mg twice daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent headache and occasional dizziness
• Key symptoms: Fatigue, blurred vision, shortness of breath on exertion
• Vital signs: Blood pressure 165/95 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F
Section 1
As the case unfolds, the patient's initial assessment reveals significant findings that demand attention. Her blood pressure remains elevated at 165/95 mmHg, despite adherence to her current medication regimen of Lisinopril and Metformin. The persistent headache and occasional dizziness she reports are accompanied by new symptoms of fatigue, blurred vision, and shortness of breath on exertion. A physical examination highlights mild bilateral pedal edema, suggesting possible fluid retention, which aligns with the overactivity of the Renin-Angiotensin-Aldosterone System (RAAS). Additionally, auscultation of the heart reveals an S4 gallop, indicative of left ventricular hypertrophy, a common complication in long-standing hypertension.
Laboratory tests are ordered to further assess the extent of end-organ damage. Her serum creatinine level is mildly elevated at 1.4 mg/dL, indicating potential renal impairment. The estimated glomerular filtration rate (eGFR) has decreased to 55 mL/min/1.73m², suggesting a decline in kidney function. Her lipid profile reveals elevated LDL cholesterol at 160 mg/dL and low HDL cholesterol at 38 mg/dL, which increases her cardiovascular risk. An electrocardiogram (ECG) shows signs of left ventricular hypertrophy, corroborating the physical findings. These diagnostic results emphasize the need for a comprehensive treatment plan that addresses both her hypertension and the emerging complications.
Given these developments, the healthcare team decides to adjust her treatment strategy. The Lisinopril dosage is increased to 40 mg daily, and a low-dose thiazide diuretic is added to help manage her blood pressure and reduce fluid retention. Additionally, lifestyle modifications, including dietary changes to reduce sodium intake and a structured exercise program, are recommended to address both hypertension and borderline diabetes. The team plans to closely monitor her renal function and cardiovascular status, aiming to prevent further end-organ damage and promote better overall health. This approach requires ongoing evaluation of her response to the interventions and readiness for potential adjustments based on her evolving clinical status.
Section 2
As the treatment plan is implemented, the healthcare team closely monitors the patient’s response to the interventions. Over the next few weeks, there are notable changes in her clinical status. Initially, the addition of the thiazide diuretic appears to be effective, as her blood pressure begins to show a gradual decrease, averaging around 150/90 mmHg. The reduction in fluid retention is evident, with a decrease in pedal edema and an improvement in her shortness of breath on exertion. However, the patient continues to experience fatigue and reports new episodes of nocturia, raising concerns about her renal function and the potential need for further medication adjustments.
A follow-up set of laboratory tests is conducted to assess her renal function and overall metabolic status. The results reveal a slight increase in serum creatinine to 1.6 mg/dL, indicating a potential worsening of renal impairment. Her eGFR has further declined to 50 mL/min/1.73m², warranting a careful evaluation of her medication regimen, as both Lisinopril and the thiazide diuretic can impact kidney function. Additionally, her lipid profile shows minimal improvement, with LDL cholesterol remaining elevated at 155 mg/dL, suggesting that dietary changes alone may not be sufficient to address her cardiovascular risk.
Given these findings, the healthcare team considers further modifications to her treatment plan. The possibility of introducing a statin to manage her dyslipidemia is discussed, along with a more aggressive approach to lifestyle modifications. The patient is encouraged to maintain a low-sodium diet, engage in regular physical activity, and monitor her blood pressure at home. Regular follow-up appointments are scheduled to reassess her condition, focusing on preventing further renal decline and optimizing her cardiovascular health. These developments underscore the importance of a dynamic and individualized approach to managing complex cases of hypertension with emerging complications.
Section 3
As the healthcare team continues to adjust the treatment plan, the patient returns for a follow-up appointment, presenting new complications that require careful consideration. She reports increased fatigue and muscle cramps, which have become more frequent and severe. During the physical examination, the nurse notes that her blood pressure has slightly increased again to 160/95 mmHg, and her heart rate is steady at 72 beats per minute. The patient also complains of occasional dizziness when standing up, which could suggest orthostatic hypotension or electrolyte imbalance. Given these new symptoms, the team decides to conduct additional blood tests to evaluate her electrolyte levels and assess her overall clinical status.
The laboratory results reveal hypokalemia, with her serum potassium level dropping to 3.2 mEq/L, potentially due to the thiazide diuretic, which is known to cause potassium loss. Her serum sodium is within normal limits, but the slight elevation of serum creatinine persists at 1.7 mg/dL, indicating ongoing concern for her renal function. The healthcare team recognizes the need for prompt intervention to address the electrolyte imbalance, as this could further exacerbate her cardiovascular risk and contribute to her reported symptoms. The decision is made to adjust her diuretic regimen, possibly reducing the dose or switching to a potassium-sparing alternative, and to consider the addition of potassium supplements to stabilize her levels.
These developments highlight the importance of continuous monitoring and adaptation of the treatment plan to manage both the primary condition of hypertension and its emerging complications. The team emphasizes to the patient the necessity of adhering to dietary recommendations, particularly increasing potassium-rich foods, and the importance of consistent medication management. With these strategic adjustments, the goal is to stabilize her symptoms, protect her kidney function, and optimize her overall cardiovascular health, setting the stage for her next phase of care.
Section 4
As the patient returns for her next follow-up appointment, the healthcare team notes several changes in her status that warrant further investigation. Her blood pressure has decreased to 150/90 mmHg following the adjustment in her diuretic regimen, but she continues to experience muscle cramps, although their frequency has slightly diminished. The patient reports that she has been more diligent in incorporating potassium-rich foods into her diet, which may be contributing to the subtle improvement in symptoms. However, she still feels fatigued and occasionally experiences dizziness, particularly in the mornings.
The recent laboratory tests indicate an improvement in her serum potassium level, now at 3.5 mEq/L, signaling a positive response to the dietary changes and potassium supplementation. Despite this, her serum creatinine remains elevated at 1.8 mg/dL, suggesting that her renal function still requires close monitoring. The team decides to further evaluate her kidney function through a glomerular filtration rate (GFR) test to better understand the extent of her renal impairment. Additionally, her ECG shows no significant abnormalities, but the persistently high blood pressure continues to be a concern for potential long-term cardiovascular complications.
Given these findings, the healthcare team emphasizes the importance of maintaining a delicate balance between managing her hypertension and protecting her renal health. They consider the introduction of an ACE inhibitor, which may provide renal protective benefits while also aiding in blood pressure control. The patient is advised on the importance of medication adherence, lifestyle modifications, and regular follow-ups to monitor her response to the new treatment plan. The team's goal is to mitigate the progression of any complications and to support the patient's journey towards improved health outcomes.
Section 5
As the patient continues her follow-up visits, the healthcare team observes a notable change in her status. Despite the initial improvement in blood pressure and potassium levels, she begins to experience more pronounced episodes of dizziness, now accompanied by palpitations and shortness of breath upon exertion. These symptoms prompt an immediate re-evaluation of her current medication regimen and lifestyle habits. Her blood pressure reading today is 142/88 mmHg, indicating a slight improvement, yet her pulse rate is elevated at 102 beats per minute. Upon further questioning, the patient reveals that her dizziness and palpitations are most severe when she transitions from sitting to standing, suggesting possible orthostatic hypotension.
The team decides to conduct additional diagnostic tests to rule out any new complications. A repeat ECG is performed, which now shows occasional premature ventricular contractions (PVCs), a change from her previous results. Concerned about the potential impact of the ACE inhibitor and diuretic combination, the healthcare providers request a repeat serum electrolyte panel. The results reveal that her serum sodium has dropped to 132 mEq/L, indicating mild hyponatremia, which could be contributing to her symptoms. Her GFR is calculated at 55 mL/min/1.73m², confirming chronic kidney disease stage 3, which necessitates careful consideration of further treatment adjustments.
In response to these findings, the healthcare team re-evaluates the patient's medication regimen with a focus on optimizing her cardiovascular and renal health while preventing electrolyte imbalances. They consider adjusting the dosage of her diuretic and ACE inhibitor and emphasize the importance of monitoring her daily fluid intake and dietary sodium levels. The patient is counseled on recognizing signs of electrolyte disturbances and encouraged to maintain regular follow-up appointments to closely monitor her condition. This step is crucial in preventing the progression of her renal impairment and managing her hypertension effectively to avert further cardiovascular complications.